Although there are conflicting results, it has been demonstrated that estrogen receptors play a role in urothelial carcinogenesis, cancer progression, and regulating chemosensitivity in bladder cancer [34,35]. This evidence concerns the gene ESR1 and urinary bladder carcinoma.